Suppr超能文献

器官毒性危害评估方法:预测心脏、肾脏和肺部毒性的现状与未来需求

approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities.

作者信息

Bassan Arianna, Alves Vinicius M, Amberg Alexander, Anger Lennart T, Beilke Lisa, Bender Andreas, Bernal Autumn, Cronin Mark T D, Hsieh Jui-Hua, Johnson Candice, Kemper Raymond, Mumtaz Moiz, Neilson Louise, Pavan Manuela, Pointon Amy, Pletz Julia, Ruiz Patricia, Russo Daniel P, Sabnis Yogesh, Sandhu Reena, Schaefer Markus, Stavitskaya Lidiya, Szabo David T, Valentin Jean-Pierre, Woolley David, Zwickl Craig, Myatt Glenn J

机构信息

Innovatune srl, Via Giulio Zanon 130/D, 35129 Padova, Italy.

The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, United States.

出版信息

Comput Toxicol. 2021 Nov;20. doi: 10.1016/j.comtox.2021.100188. Epub 2021 Sep 13.

Abstract

The kidneys, heart and lungs are vital organ systems evaluated as part of acute or chronic toxicity assessments. New methodologies are being developed to predict these adverse effects based on and approaches. This paper reviews the current state of the art in predicting these organ toxicities. It outlines the biological basis, processes and endpoints for kidney toxicity, pulmonary toxicity, respiratory irritation and sensitization as well as functional and structural cardiac toxicities. The review also covers current experimental approaches, including off-target panels from secondary pharmacology batteries. Current approaches for prediction of these effects and mechanisms are described as well as obstacles to the use of methods. Ultimately, a commonly accepted protocol for performing such assessment would be a valuable resource to expand the use of such approaches across different regulatory and industrial applications. However, a number of factors impede their widespread deployment including a lack of a comprehensive mechanistic understanding, limited testing approaches and limited databases suitable for modeling, a limited understanding of how to incorporate absorption, distribution, metabolism, and excretion (ADME) considerations into the overall process, a lack of models designed to predict a safe dose and an accepted framework for organizing the key characteristics of these organ toxicants.

摘要

肾脏、心脏和肺是作为急性或慢性毒性评估一部分进行评估的重要器官系统。正在开发新的方法,以基于 和 方法来预测这些不良反应。本文综述了预测这些器官毒性的当前技术水平。它概述了肾脏毒性、肺毒性、呼吸道刺激和致敏以及心脏功能和结构毒性的生物学基础、过程和终点。该综述还涵盖了当前的实验方法,包括来自二级药理学试验组合的脱靶检测组。描述了预测这些效应和机制的当前 方法以及使用 方法的障碍。最终,一个被普遍接受的进行此类评估的方案将是一种宝贵的资源,可用于在不同的监管和工业应用中扩大此类方法的使用。然而,一些因素阻碍了它们的广泛应用,包括缺乏全面的机制理解、有限的 测试方法和适用于建模的有限 数据库、对如何将吸收、分布、代谢和排泄(ADME)考虑因素纳入整个过程的理解有限、缺乏旨在预测安全剂量的 模型以及用于组织这些器官毒物关键特征的公认框架。

相似文献

2
approaches in organ toxicity hazard assessment: current status and future needs in predicting liver toxicity.
Comput Toxicol. 2021 Nov;20. doi: 10.1016/j.comtox.2021.100187. Epub 2021 Sep 9.
3
Genetic toxicology in silico protocol.
Regul Toxicol Pharmacol. 2019 Oct;107:104403. doi: 10.1016/j.yrtph.2019.104403. Epub 2019 Jun 11.
4
Approaches In Carcinogenicity Hazard Assessment: Current Status and Future Needs.
Comput Toxicol. 2021 Nov;20. doi: 10.1016/j.comtox.2021.100191. Epub 2021 Sep 23.
5
Current status and future directions for a neurotoxicity hazard assessment framework that integrates approaches.
Comput Toxicol. 2022 May;22. doi: 10.1016/j.comtox.2022.100223. Epub 2022 Mar 17.
6
In silico toxicology protocols.
Regul Toxicol Pharmacol. 2018 Jul;96:1-17. doi: 10.1016/j.yrtph.2018.04.014. Epub 2018 Apr 17.
7
In Silico Approaches in Predictive Genetic Toxicology.
Methods Mol Biol. 2019;2031:351-373. doi: 10.1007/978-1-4939-9646-9_20.
8
Principles and Procedures for Assessment of Acute Toxicity Incorporating Methods.
Comput Toxicol. 2022 Nov;24. doi: 10.1016/j.comtox.2022.100237. Epub 2022 Jul 14.
9
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
10
Skin sensitization in silico protocol.
Regul Toxicol Pharmacol. 2020 Oct;116:104688. doi: 10.1016/j.yrtph.2020.104688. Epub 2020 Jul 1.

引用本文的文献

4
A Review of the Most Frequent Compounds, Metals, and Compound and Metal Mixtures Found at U.S. Superfund Sites and Their Carcinogenic Potential.
Chem Res Toxicol. 2025 Jun 16;38(6):963-974. doi: 10.1021/acs.chemrestox.4c00506. Epub 2025 Jun 3.
6
Evaluation of antiobesogenic properties of fermented foods: In silico insights.
J Food Sci. 2025 Mar;90(3):e70074. doi: 10.1111/1750-3841.70074.
8
Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.
Front Toxicol. 2024 Apr 5;6:1370045. doi: 10.3389/ftox.2024.1370045. eCollection 2024.
9
Insights into Drug Cardiotoxicity from Biological and Chemical Data: The First Public Classifiers for FDA Drug-Induced Cardiotoxicity Rank.
J Chem Inf Model. 2024 Feb 26;64(4):1172-1186. doi: 10.1021/acs.jcim.3c01834. Epub 2024 Feb 1.
10
Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety.
Biomolecules. 2023 Oct 26;13(11):1581. doi: 10.3390/biom13111581.

本文引用的文献

1
In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.
Wiley Interdiscip Rev Comput Mol Sci. 2020 Jul-Aug;10(4):e1475. doi: 10.1002/wcms.1475. Epub 2020 Mar 31.
2
approaches in organ toxicity hazard assessment: current status and future needs in predicting liver toxicity.
Comput Toxicol. 2021 Nov;20. doi: 10.1016/j.comtox.2021.100187. Epub 2021 Sep 9.
4
Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports.
Chem Res Toxicol. 2021 Feb 15;34(2):365-384. doi: 10.1021/acs.chemrestox.0c00294. Epub 2020 Dec 22.
5
High-Throughput Screening to Identify Chemical Cardiotoxic Potential.
Chem Res Toxicol. 2021 Feb 15;34(2):566-583. doi: 10.1021/acs.chemrestox.0c00382. Epub 2020 Dec 21.
7
Skin sensitization in silico protocol.
Regul Toxicol Pharmacol. 2020 Oct;116:104688. doi: 10.1016/j.yrtph.2020.104688. Epub 2020 Jul 1.
8
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
Kidney Int. 2020 Jun;97(6):1117-1129. doi: 10.1016/j.kint.2020.02.010. Epub 2020 Mar 9.
9
A practical guide to secondary pharmacology in drug discovery.
J Pharmacol Toxicol Methods. 2020 Sep;105:106869. doi: 10.1016/j.vascn.2020.106869. Epub 2020 Apr 14.
10
Current and future approaches to nonclinical cardiovascular safety assessment.
Drug Discov Today. 2020 Jul;25(7):1129-1134. doi: 10.1016/j.drudis.2020.03.011. Epub 2020 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验